Article ID Journal Published Year Pages File Type
9194609 Journal of Neuroimmunology 2005 4 Pages PDF
Abstract
Neuronal growth factors may exert a neuroprotective effect in multiple sclerosis (MS). We found reduced levels of brain-derived neurotrophic factors (BDNF) in the serum and CSF of relapsing-remitting MS patients, which was reversed by therapy with glatiramer acetate. BDNF may play a protective role in MS, and immunomodulation therapy, such as with glatiramer acetate, may enhance the action this mechanism.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , ,